171 related articles for article (PubMed ID: 35640246)
1. A randomized controlled trial comparing perioperative vs. postoperative mFOLFOX6 for lower rectal cancer with suspected lateral pelvic lymph node metastasis (JCOG1310): a phase II/III randomized controlled trial.
Ohue M; Iwasa S; Mizusawa J; Kanemitsu Y; Shiozawa M; Nishizawa Y; Ueno H; Katsumata K; Yasui M; Tsukamoto S; Katayama H; Fukuda H; Shimada Y
Jpn J Clin Oncol; 2022 Aug; 52(8):850-858. PubMed ID: 35640246
[TBL] [Abstract][Full Text] [Related]
2. A Phase II/III randomized controlled trial comparing perioperative versus postoperative chemotherapy with mFOLFOX6 for lower rectal cancer with suspected lateral pelvic node metastasis: Japan Clinical Oncology Group Study JCOG1310 (PRECIOUS study).
Ohue M; Iwasa S; Kanemitsu Y; Hamaguchi T; Shiozawa M; Ito M; Yasui M; Katayama H; Mizusawa J; Shimada Y;
Jpn J Clin Oncol; 2017 Jan; 47(1):84-87. PubMed ID: 27655905
[TBL] [Abstract][Full Text] [Related]
3. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors of pathological lateral pelvic lymph node metastasis in patients without clinical lateral pelvic lymph node metastasis (clinical stage II/III): The analysis of data from the clinical trial (JCOG0212).
Komori K; Fujita S; Mizusawa J; Kanemitsu Y; Ito M; Shiomi A; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Kinugasa Y; Takii Y; Akasu T; Moriya Y;
Eur J Surg Oncol; 2019 Mar; 45(3):336-340. PubMed ID: 30477950
[TBL] [Abstract][Full Text] [Related]
5. [Transanal lateral lymph node dissection surgery for 5 cases of mid-low rectal cancer].
Zeng ZW; Zhang XW; Chen JJ; Huang L; Luo SL; Kang L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Aug; 22(8):781-785. PubMed ID: 31422618
[No Abstract] [Full Text] [Related]
6. Urinary dysfunction after rectal cancer surgery: Results from a randomized trial comparing mesorectal excision with and without lateral lymph node dissection for clinical stage II or III lower rectal cancer (Japan Clinical Oncology Group Study, JCOG0212).
Ito M; Kobayashi A; Fujita S; Mizusawa J; Kanemitsu Y; Kinugasa Y; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Akasu T; Moriya Y;
Eur J Surg Oncol; 2018 Apr; 44(4):463-468. PubMed ID: 29428473
[TBL] [Abstract][Full Text] [Related]
7. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
[TBL] [Abstract][Full Text] [Related]
8. Lateral pelvic lymph node dissection after neoadjuvant chemo-radiation for preoperative enlarged lateral nodes in advanced low rectal cancer: study protocol for a randomized controlled trial.
Wei M; Wu Q; Fan C; Li Y; Chen X; Zhou Z; Han J; Wang Z
Trials; 2016 Nov; 17(1):561. PubMed ID: 27884204
[TBL] [Abstract][Full Text] [Related]
9. Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial.
Deng Y; Chi P; Lan P; Wang L; Chen W; Cui L; Chen D; Cao J; Wei H; Peng X; Huang Z; Cai G; Zhao R; Huang Z; Xu L; Zhou H; Wei Y; Zhang H; Zheng J; Huang Y; Zhou Z; Cai Y; Kang L; Huang M; Peng J; Ren D; Wang J
J Clin Oncol; 2016 Sep; 34(27):3300-7. PubMed ID: 27480145
[TBL] [Abstract][Full Text] [Related]
10. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease?
Akiyoshi T; Watanabe T; Miyata S; Kotake K; Muto T; Sugihara K;
Ann Surg; 2012 Jun; 255(6):1129-34. PubMed ID: 22549752
[TBL] [Abstract][Full Text] [Related]
11. A prospective, single-arm, multicenter trial of neoadjuvant chemotherapy with mFOLFOX6 plus panitumumab without radiotherapy for locally advanced rectal cancer.
Toritani K; Watanabe J; Suwa Y; Nakagawa K; Suwa H; Ishibe A; Ota M; Kunisaki C; Yamanaka T; Endo I
Int J Colorectal Dis; 2020 Dec; 35(12):2197-2204. PubMed ID: 32725346
[TBL] [Abstract][Full Text] [Related]
12. Lateral pelvic lymph node metastasis in T2 low rectal cancer: is TME alone sufficient for cure?
Ouchi A; Inoue M; Sato Y; Takamizawa Y; Kinoshita T; Moritani K; Komori K; Tsukamoto S; Shimizu Y; Kanemitsu Y
Jpn J Clin Oncol; 2023 Apr; 53(5):386-392. PubMed ID: 36722355
[TBL] [Abstract][Full Text] [Related]
13. Mesorectal excision with or without lateral lymph node dissection for elderly patients with mid-low rectal cancer: safety and feasibility analysis.
Zhou S; Mei S; Feng B; Yang Y; Wang X; Wang Q; Liu Q;
Jpn J Clin Oncol; 2023 Jan; 53(1):26-34. PubMed ID: 36354102
[TBL] [Abstract][Full Text] [Related]
14. Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial.
Fujita S; Mizusawa J; Kanemitsu Y; Ito M; Kinugasa Y; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Murata K; Akagi Y; Takiguchi N; Saida Y; Nakamura K; Fukuda H; Akasu T; Moriya Y;
Ann Surg; 2017 Aug; 266(2):201-207. PubMed ID: 28288057
[TBL] [Abstract][Full Text] [Related]
15. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.
Garcia-Aguilar J; Chow OS; Smith DD; Marcet JE; Cataldo PA; Varma MG; Kumar AS; Oommen S; Coutsoftides T; Hunt SR; Stamos MJ; Ternent CA; Herzig DO; Fichera A; Polite BN; Dietz DW; Patil S; Avila K;
Lancet Oncol; 2015 Aug; 16(8):957-66. PubMed ID: 26187751
[TBL] [Abstract][Full Text] [Related]
16. Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil, and Leucovorin Versus Oxaliplatin, 5-Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG-ACRIN Research Group (E5204).
Chakravarthy AB; Zhao F; Meropol NJ; Flynn PJ; Wagner LI; Sloan J; Diasio RB; Mitchell EP; Catalano P; Giantonio BJ; Catalano RB; Haller DG; Awan RA; Mulcahy MF; O'Brien TE; Santala R; Cripps C; Weis JR; Atkins JN; Leichman CG; Petrelli NJ; Sinicrope FA; Brierley JD; Tepper JE; O'Dwyer PJ; Sigurdson ER; Hamilton SR; Cella D; Benson AB
Oncologist; 2020 May; 25(5):e798-e807. PubMed ID: 31852811
[TBL] [Abstract][Full Text] [Related]
17. Exploratory analysis of lateral pelvic sentinel lymph node status for optimal management of laparoscopic lateral lymph node dissection in advanced lower rectal cancer without suspected lateral lymph node metastasis.
Yasui M; Ohue M; Noura S; Miyoshi N; Takahashi Y; Matsuda C; Nishimura J; Haraguchi N; Ushigome H; Nakai N; Fujino S; Sugimura K; Wada H; Takahashi H; Omori T; Miyata H
BMC Cancer; 2021 Aug; 21(1):911. PubMed ID: 34380428
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic Versus Open Lateral Lymph Node Dissection for Locally Advanced Low Rectal Cancer: A Subgroup Analysis of a Large Multicenter Cohort Study in Japan.
Yamaguchi T; Konishi T; Kinugasa Y; Yamamoto S; Akiyoshi T; Okamura R; Ito M; Nishimura Y; Shiozawa M; Yamaguchi S; Hida K; Sakai Y; Watanabe M
Dis Colon Rectum; 2017 Sep; 60(9):954-964. PubMed ID: 28796734
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial.
Akasu T; Moriya Y; Ohashi Y; Yoshida S; Shirao K; Kodaira S;
Jpn J Clin Oncol; 2006 Apr; 36(4):237-44. PubMed ID: 16675478
[TBL] [Abstract][Full Text] [Related]
20. Phase II Trial of Neoadjuvant Chemotherapy, Chemoradiotherapy, and Laparoscopic Surgery with Selective Lateral Node Dissection for Poor-Risk Low Rectal Cancer.
Konishi T; Shinozaki E; Murofushi K; Taguchi S; Fukunaga Y; Nagayama S; Fujimoto Y; Akiyoshi T; Nagasaki T; Suenaga M; Chino A; Kawachi H; Yamamoto N; Ishikawa Y; Oguchi M; Ishizuka N; Ueno M; Yamaguchi K
Ann Surg Oncol; 2019 Aug; 26(8):2507-2513. PubMed ID: 30963400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
